GYY4137 exhibits neuroprotective effects in Alzheimer's disease models by promoting the sulfhydration of glycogen synthase kinase 3β (GSK3β), thereby inhibiting tau hyperphosphorylation, a critical step in neurofibrillary tangle formation. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.